ArticleHIV medicine2025
The peripartum viral load cascade and outcomes of infants exposed to HIV in Lesotho.
Article in HIV medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- HIV epidemic in Lesotho - HIV treatment and monitoring of patients on antiretroviral therapy 2014-2024.PLOS global public health · 2026Article
- The peripartum viral load cascade and outcomes of infants exposed to HIV in Lesotho.HIV medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectivesThis study describes the peripartum viral load (VL) monitoring cascade among individuals initiating antiretroviral therapy (ART) before delivery, as well as HIV testing, prophylaxis and outcomes of their infants in routine care in Lesotho, southern Africa.
methodsData from medical charts review of paper-based registers at 20 healthcare facilities in two districts of Lesotho were combined with data from the Viral Load Cohort North-East Lesotho (VICONEL). We included people with HIV who attended their first antenatal care visit at a participating healthcare facility after 31 December 2019, had a delivery date before 1 January 2022 and initiated dolutegravir-based ART before delivery, as well as their infants.
resultsA total of 353 pregnant people with HIV and 357 infants exposed to HIV were recorded. Among 17/353 (5%) with an initial VL ≥1000 copies/mL, a timely (within 4 months) follow-up VL was provided for 4/17 (24%). Among 233/353 (66%) with an initial VL <1000 copies/mL, a timely (within 7 months) follow-up VL was provided for 120/233 (52%). For 103/353 (29%), no VL measurement was available during pregnancy. Overall, peripartum VL monitoring was guideline-adherent for 157/353 (44%) pregnancies. Among infants exposed to HIV, 301/357 (84%), 274/357 (77%) and 172/357 (48%) received guideline-adherent prophylactic ART, early infant HIV testing within 2 months and 9-month HIV testing, respectively. Vertical transmissions occurred in 2/357 (1%) infants.
conclusionThere were substantial gaps in peripartum HIV service delivery or uptake as well as in HIV prevention and testing of infants exposed to HIV.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.